BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 19155284)

  • 21. Microinvasive ductal carcinoma arising within a fibroadenoma: A case report.
    Shin JH; Choi HY; Lee SN; Kim YJ
    Acta Radiol; 2006 Sep; 47(7):643-5. PubMed ID: 16950696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ductal carcinoma in situ.
    Rosai J
    Hum Pathol; 1996 Nov; 27(11):1247. PubMed ID: 8912841
    [No Abstract]   [Full Text] [Related]  

  • 23. Breast screening. Reality of ductal carcinoma in situ.
    Flanders J
    BMJ; 2009 Mar; 338():b958. PubMed ID: 19273513
    [No Abstract]   [Full Text] [Related]  

  • 24. Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast (Br J Surg 2008; 95: 547-554).
    Meijnen P; Rutgers EJ
    Br J Surg; 2008 Oct; 95(10):1305; author reply 1305. PubMed ID: 18763257
    [No Abstract]   [Full Text] [Related]  

  • 25. Developing a prognostic index for ductal carcinoma in situ of the breast. Are we there yet?
    Silverstein MJ; Craig PH; Lagios MD; Waisman JK; Lewinsky BS; Colburn WJ; Poller DN
    Cancer; 1996 Sep; 78(5):1138-40. PubMed ID: 8780555
    [No Abstract]   [Full Text] [Related]  

  • 26. In situ and infiltrating ductal carcinoma arising in a breast hamartoma.
    Mester J; Simmons RM; Vazquez MF; Rosenblatt R
    AJR Am J Roentgenol; 2000 Jul; 175(1):64-6. PubMed ID: 10882247
    [No Abstract]   [Full Text] [Related]  

  • 27. Will ductal carcinoma in situ defeat breast cancer screening?
    Benson JR
    BMJ; 2009 Mar; 338():b957. PubMed ID: 19273512
    [No Abstract]   [Full Text] [Related]  

  • 28. Cytologic characteristics of endocrine ductal carcinoma in situ of the breast. A case report.
    Yin H; Schinella R
    Acta Cytol; 2002; 46(5):873-6. PubMed ID: 12365222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In-situ ductal carcinoma of the breast].
    Rinderknecht B; Giudici G; Meister F
    Schweiz Med Wochenschr; 1995 May; 125(19):978. PubMed ID: 7619169
    [No Abstract]   [Full Text] [Related]  

  • 30. More on breast cancer guidelines.
    Ramsay WR
    CMAJ; 1998 Jun; 158(11):1427, 1429; author reply 1429-30. PubMed ID: 9629099
    [No Abstract]   [Full Text] [Related]  

  • 31. Ductal carcinoma in situ with periductal fibrosis -- is it in reality an invasive carcinoma?
    Naresh KN; Borges AM
    Hum Pathol; 1996 Jul; 27(7):744. PubMed ID: 8698323
    [No Abstract]   [Full Text] [Related]  

  • 32. Diagnosis of recurrent breast cancer by ductoscopy.
    Valdes EK; Feldman SM; Balassanian R; Cohen JM; Boolbol SK
    Breast J; 2005; 11(6):506. PubMed ID: 16297117
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of serum progesterone concentration for timing breast MRI examinations and avoiding false-negative findings.
    Ganau S; Sentís M; Tortajada L
    AJR Am J Roentgenol; 2010 Jul; 195(1):W85; author reply W86. PubMed ID: 20566787
    [No Abstract]   [Full Text] [Related]  

  • 34. Pathology and clinical evolution of ductal carcinoma in situ (DCIS) of the breast.
    Page DL; Lagios MD
    Cancer Lett; 1994 Oct; 86(1):1-4. PubMed ID: 7954344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carcinoma arising within fibroadenoma--a case report.
    Vaideeswar P; Madiwale C; Sivaraman A
    Indian J Pathol Microbiol; 2000 Jan; 43(1):87-9. PubMed ID: 12583428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A method of coil localization for breast lesions seen only on MRI.
    Warren R; Kessar P
    Br J Radiol; 2001 Jun; 74(882):548-51. PubMed ID: 11459734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. False-negative core biopsy of the breast.
    Racenstein MJ; Berlin L
    AJR Am J Roentgenol; 1998 Oct; 171(4):927-30. PubMed ID: 9762970
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of magnetic resonance imaging for detecting clinically and mammographically occult ductal carcinoma in situ.
    Lo G; Cheung P
    Hong Kong Med J; 2008 Jun; 14(3):229-32. PubMed ID: 18525094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic resonance imaging in patients with ductal carcinoma in situ: routine, selective, or not at all?
    Margenthaler JA
    Ann Surg Oncol; 2014 May; 21(5):1510-1. PubMed ID: 24368563
    [No Abstract]   [Full Text] [Related]  

  • 40. The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?
    Lakhani SR; Audretsch W; Cleton-Jensen AM; Cutuli B; Ellis I; Eusebi V; Greco M; Houslton RS; Kuhl CK; Kurtz J; Palacios J; Peterse H; Rochard F; Rutgers E;
    Eur J Cancer; 2006 Sep; 42(14):2205-11. PubMed ID: 16876991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.